Skip to main content
. 2013 Mar 7;12:19. doi: 10.1186/1476-4598-12-19

Figure 1.

Figure 1

Quizartinib inhibits cellular proliferation of KIT-, FLT3- or PDGFR-dependent leukemia cells. Dilution series of quizartinib for several cell lines harboring mutant-FLT3, ABL1 or PDGFRA (1A) or mutant-KIT isoforms (1B) were performed and cellular proliferation was assessed using an XTT-based assay. Sensitivity towards quizartinib varied widely between the tested cell lines. IC50s and mutation isoforms for all tested cell lines are listed in Table 1.

  NODES